Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap W Groothoff

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2010
Determinants of eGFR at start of renal replacement therapy in paediatric patientsKarlijn J van Stralen, E Jane Tizard, Kitty J Jager, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2013
Underweight, overweight and obesity in paediatric dialysis and renal transplant patientsMarjolein Bonthuis, Karlijn J van Stralen, Enrico Verrina, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2022
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C TrialMini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated NephropathyÜnsal Yapici, Jesper Kers, Ivana Slavujevic-Letic, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 14, 2025
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C TrialAnne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, et al.
The Lancet. Child & Adolescent Health|May 17, 2024
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registriesM Doortje Reijman, Tycho R Tromp, Barbara A Hutten, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W Groothoff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2013
Children of non-Western origin with end-stage renal disease in the Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with Western childrenNikki J Schoenmaker, Lotte Haverman, Wilma F Tromp, et al.
Nature Reviews. Nephrology|January 5, 2023
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEuropeJaap W Groothoff, Ella Metry, Lisa Deesker, et al.
Kidney International Reports|February 14, 2022
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) RegistryElisabeth L Metry, Sander F Garrelfs, Hessel Peters-Sengers, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2010
Determinants of eGFR at start of renal replacement therapy in paediatric patientsKarlijn J van Stralen, E Jane Tizard, Kitty J Jager, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2013
Underweight, overweight and obesity in paediatric dialysis and renal transplant patientsMarjolein Bonthuis, Karlijn J van Stralen, Enrico Verrina, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2022
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C TrialMini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated NephropathyÜnsal Yapici, Jesper Kers, Ivana Slavujevic-Letic, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 14, 2025
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C TrialAnne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, et al.
The Lancet. Child & Adolescent Health|May 17, 2024
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registriesM Doortje Reijman, Tycho R Tromp, Barbara A Hutten, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W Groothoff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2013
Children of non-Western origin with end-stage renal disease in the Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with Western childrenNikki J Schoenmaker, Lotte Haverman, Wilma F Tromp, et al.
Nature Reviews. Nephrology|January 5, 2023
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEuropeJaap W Groothoff, Ella Metry, Lisa Deesker, et al.
Kidney International Reports|February 14, 2022
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) RegistryElisabeth L Metry, Sander F Garrelfs, Hessel Peters-Sengers, et al.
Pageof 15